BASIC RESEARCH FOR MECHANISM OF ORGAN FAILURE IN CANCER PATIENTS WITH PARANEOPLASTIC SYNDROME-PROPHYLAXY AND TREATMENT OF PARANEOPLASTIC SYNDROME BY REGULATION OF CYTOKINE PRODUCTION-
副肿瘤综合征癌症患者器官衰竭机制的基础研究-通过调节细胞因子产生预防和治疗副肿瘤综合征-
基本信息
- 批准号:10671125
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In cancer patients with cachexia and paraneoplastic syndrome, it is important to clarify a role of tumor-producing proinflammatory cytokines, such as TNF-α, IL-1 and IL-6, which also play a critical role in organ dysfunction seen in trauma and infection. In the present study, to explore the effect of lipopolysaccharides(LPS) on the survival, serum cytokine level, ICAM-1 expression, and pathological change of various organ in tumor-bearing mice in which tumor produces IL-6 constitutively.Enzyme-linked-immunosorbent assay and histochemical studies were performed on colon 26 clone5 (c5), low producer of IL-6 or clone20(c20), high producer of IL-6-implanted BALB/c mice treated with LPS. LPS at 20, 50, 115 μg body was administered 7day after inoculation. The sera and organs were collected 2days after LPS administration. 20 or 50 μg of LPS did not shorten the survival period of c5 or c20 bearing mice. A higher survival rate was found in c5 or c20 bearing mice when compared with normal mice given 115 μg LPS. Serum IL-1β increased proportionally with LPS administration in normaland c5-bearing mice groups. Only normal mice showed serum IL-6 rising with LPS administration proportionally. Enhanced expression of ICAM-1 was seen only in normal mice given ll5 μg LPS. These results suggest that the effects of sublethal doses of LPS on the survival were attenuated on IL-6-producing-cancer-bearing mice. It is not likely that modulation of tumor-producing cytokine is effective strategy for prophylaxis of organ dysfunction related to infection in cancer patients with cachexia and paraneoplastic syndrome.
在患有恶病质和副肿瘤综合征的癌症患者中,重要的是澄清产生肿瘤的促炎细胞因子的作用,如肿瘤坏死因子-α、IL-1和IL-6,这些细胞因子在创伤和感染中出现的器官功能障碍中也发挥着关键作用。为探讨脂多糖对IL-6荷瘤小鼠存活时间、血清细胞因子水平、ICAM-1表达及各脏器病理改变的影响,对IL-6低分泌克隆26克隆(C5)和高分泌IL-6克隆BALB/c小鼠(C20)进行了酶联免疫吸附试验和组织化学研究。分别于接种后7天注射20、50、115μg体重的脂多糖。于注射脂多糖后2天采集血清和脏器。20或50μg的脂多糖不能缩短C5或C20荷瘤小鼠的存活时间。与正常小鼠相比,C5或C20荷瘤小鼠的存活率明显提高(P<0.0 5),注射115GLPS的小鼠存活率明显升高(P<0.0 5)。μg LPS115 mg/kg组小鼠存活率明显高于对照组。正常组和C5荷瘤组小鼠血清IL-1β水平与注射脂多糖成正比。只有正常小鼠血清IL-6水平与注射内毒素成比例升高。细胞间黏附分子-1的表达仅在给予LL5μg脂多糖的正常小鼠中可见增强。这些结果表明,亚致死剂量的内毒素对荷IL-6荷瘤小鼠存活的影响被减弱。肿瘤细胞因子的调节不太可能是预防癌症患者恶病质和副肿瘤综合征患者感染相关器官功能障碍的有效策略。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
M. Miyazaki, S. Mita, S. Suzuki, H. Hidaka, O. Ikeda and M. Ogawa: "Effects of Sublethal dose of lipopolysaccharides(LPS) on the survival of tumor bearing mice with cancer cachexia. 5th World Congress on Trauma, Shock, Inflammation and Sepsis, Pathophysio
M. Miyazaki、S. Mita、S. Suzuki、H. Hidaka、O. Ikeda 和 M. Okawa:“亚致死剂量的脂多糖 (LPS) 对患有癌症恶病质的荷瘤小鼠的存活率的影响。第五届世界创伤大会
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
鈴木俊二 他: "癌の進展におけるサイトカインネットワークの意義"消化器癌の発生と進展. 10. 153-155 (1998)
Shunji Suzuki 等:“细胞因子网络在癌症进展中的意义”胃肠道癌症的发生和进展(1998)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MITA Seiji其他文献
MITA Seiji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Role of purinergic signaling in pediatric multi-organ failure
嘌呤能信号在儿童多器官衰竭中的作用
- 批准号:
10671089 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
The Platelet Transcriptome and Organ Failure After Injury: Discovering Molecular Biomarkers and Preventative Targets through Interrogating Novel RNA Modifications
血小板转录组和损伤后器官衰竭:通过研究新的 RNA 修饰发现分子生物标志物和预防靶点
- 批准号:
10711791 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Role of purinergic signaling in pediatric multi-organ failure
嘌呤能信号在儿童多器官衰竭中的作用
- 批准号:
10829152 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Targeting immune cells derived from tumor clones in the pathogenesis of hematological malignancy-related systemic organ failure
在血液恶性肿瘤相关的全身器官衰竭的发病机制中靶向肿瘤克隆衍生的免疫细胞
- 批准号:
23H02752 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Basic research to prevent ventilator-induced organ failure targeting "regulated necrosis".
针对“调节性坏死”的预防呼吸机引起的器官衰竭的基础研究。
- 批准号:
21K16575 - 财政年份:2021
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Neutrophil extracellular traps contribute multiple organ failure after traumatic brain injury
中性粒细胞胞外陷阱导致脑外伤后多器官衰竭
- 批准号:
21K17324 - 财政年份:2021
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Preventing organ failure in sepsis by NAD(+) repletion: mechanistic insights and therapeutic potential
通过补充 NAD() 预防脓毒症中的器官衰竭:机制见解和治疗潜力
- 批准号:
450507 - 财政年份:2021
- 资助金额:
$ 2.05万 - 项目类别:
Operating Grants
The effect of Antithrombin Therapy against Maltiple Organ failure in Rhabdomyolysis
抗凝血酶治疗对横纹肌溶解症多器官功能衰竭的影响
- 批准号:
20K17887 - 财政年份:2020
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A investigation of a role of remote organ failure after tissue injury using our new tissue injury model.
使用我们的新组织损伤模型研究组织损伤后远程器官衰竭的作用。
- 批准号:
19K09405 - 财政年份:2019
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of activity of HMGB1 and therapeutic prospects in multiple organ failure caused by traumatic hemorrhagic shock
HMGB1活性的阐明和创伤失血性休克引起的多器官功能衰竭的治疗前景
- 批准号:
19K18337 - 财政年份:2019
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




